Abby Spangler, Geoffrey D. Shimberg, Grace E. Mantus, Rory Malek, Lauren Y. Cominsky, Yaroslav Tsybovsky, Ning Li, Rebecca A. Gillespie, Michelle Ravichandran, Adrian Creanga, Julie E. Raab, Suprabhath R. Gajjala, Floreliz Mendoza, Katherine V. Houser, Lesia Dropulic, Adrian B. McDermott, Masaru Kanekiyo, Sarah F. Andrews
{"title":"早期流感病毒暴露影响50年后个体对流感疫苗接种的B细胞反应","authors":"Abby Spangler, Geoffrey D. Shimberg, Grace E. Mantus, Rory Malek, Lauren Y. Cominsky, Yaroslav Tsybovsky, Ning Li, Rebecca A. Gillespie, Michelle Ravichandran, Adrian Creanga, Julie E. Raab, Suprabhath R. Gajjala, Floreliz Mendoza, Katherine V. Houser, Lesia Dropulic, Adrian B. McDermott, Masaru Kanekiyo, Sarah F. Andrews","doi":"10.1016/j.immuni.2025.02.004","DOIUrl":null,"url":null,"abstract":"Pre-existing immunity impacts vaccine responses to influenza, but directly connecting influenza infections early in life with immune responses decades later is difficult. However, H2N2 stopped circulating in the human population in 1968, creating the opportunity to directly evaluate the impact of early H2N2 exposure on vaccine responses 50 years later. Here, we vaccinated individuals born before (H2 exposed) or after (H2 naive) 1968 with an H2 hemagglutinin (HA) DNA plasmid and/or a ferritin nanoparticle vaccine. H2-exposed individuals generated a rapid B cell recall response that was more potent, targeted more conserved epitopes, and differed phenotypically from the <em>de novo</em> response in H2-naive individuals. Furthermore, vaccinating with a DNA versus a protein nanoparticle vaccine altered the response in H2-naive but not H2-exposed individuals. This study establishes and describes the lifelong impact of influenza HA-specific memory B cells formed early in life on vaccine responses decades later.","PeriodicalId":13269,"journal":{"name":"Immunity","volume":"85 1","pages":""},"PeriodicalIF":25.5000,"publicationDate":"2025-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Early influenza virus exposure shapes the B cell response to influenza vaccination in individuals 50 years later\",\"authors\":\"Abby Spangler, Geoffrey D. Shimberg, Grace E. Mantus, Rory Malek, Lauren Y. Cominsky, Yaroslav Tsybovsky, Ning Li, Rebecca A. Gillespie, Michelle Ravichandran, Adrian Creanga, Julie E. Raab, Suprabhath R. Gajjala, Floreliz Mendoza, Katherine V. Houser, Lesia Dropulic, Adrian B. McDermott, Masaru Kanekiyo, Sarah F. Andrews\",\"doi\":\"10.1016/j.immuni.2025.02.004\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Pre-existing immunity impacts vaccine responses to influenza, but directly connecting influenza infections early in life with immune responses decades later is difficult. However, H2N2 stopped circulating in the human population in 1968, creating the opportunity to directly evaluate the impact of early H2N2 exposure on vaccine responses 50 years later. Here, we vaccinated individuals born before (H2 exposed) or after (H2 naive) 1968 with an H2 hemagglutinin (HA) DNA plasmid and/or a ferritin nanoparticle vaccine. H2-exposed individuals generated a rapid B cell recall response that was more potent, targeted more conserved epitopes, and differed phenotypically from the <em>de novo</em> response in H2-naive individuals. Furthermore, vaccinating with a DNA versus a protein nanoparticle vaccine altered the response in H2-naive but not H2-exposed individuals. This study establishes and describes the lifelong impact of influenza HA-specific memory B cells formed early in life on vaccine responses decades later.\",\"PeriodicalId\":13269,\"journal\":{\"name\":\"Immunity\",\"volume\":\"85 1\",\"pages\":\"\"},\"PeriodicalIF\":25.5000,\"publicationDate\":\"2025-02-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Immunity\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.immuni.2025.02.004\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Immunity","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.immuni.2025.02.004","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
Early influenza virus exposure shapes the B cell response to influenza vaccination in individuals 50 years later
Pre-existing immunity impacts vaccine responses to influenza, but directly connecting influenza infections early in life with immune responses decades later is difficult. However, H2N2 stopped circulating in the human population in 1968, creating the opportunity to directly evaluate the impact of early H2N2 exposure on vaccine responses 50 years later. Here, we vaccinated individuals born before (H2 exposed) or after (H2 naive) 1968 with an H2 hemagglutinin (HA) DNA plasmid and/or a ferritin nanoparticle vaccine. H2-exposed individuals generated a rapid B cell recall response that was more potent, targeted more conserved epitopes, and differed phenotypically from the de novo response in H2-naive individuals. Furthermore, vaccinating with a DNA versus a protein nanoparticle vaccine altered the response in H2-naive but not H2-exposed individuals. This study establishes and describes the lifelong impact of influenza HA-specific memory B cells formed early in life on vaccine responses decades later.
期刊介绍:
Immunity is a publication that focuses on publishing significant advancements in research related to immunology. We encourage the submission of studies that offer groundbreaking immunological discoveries, whether at the molecular, cellular, or whole organism level. Topics of interest encompass a wide range, such as cancer, infectious diseases, neuroimmunology, autoimmune diseases, allergies, mucosal immunity, metabolic diseases, and homeostasis.